arrow
T

Tomoya Yokota

Department of Head and Neck Medical Oncology
H指数:37
被引数:7,890

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus–associated oropharyngeal cancer: a multicentre Phase II trial

新辅助三联化疗使人类乳头瘤病毒相关口咽癌患者避免放疗:一项多中心II期临床试验

2026-09-050
PRE
Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer

更正:局部晚期同步食管癌和头颈癌的多模式治疗

2026-07-090
PREAI
Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trial

高风险头颈癌术后放化疗相关吸入性肺炎的危险因素:JCOG1008期II/III临床试验的补充分析

2026-04-180
PRE
Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: a randomized, non-comparative trial

内镜超声引导下组织采样进行基因组分析的最佳穿刺次数:一项随机、非对照试验

2025-06-280
PRE
A randomized, double-blind, placebo-controlled phase III study evaluating the preventive effect of diclofenac cream on capecitabine-related hand-foot syndrome: study protocol of J-SUPPORT2401/JORTC-SUP06 (J-DIRECT)

一项随机、双盲、安慰剂对照的III期研究,评估双氯芬酸乳膏对卡培他滨相关手足综合征的预防效果:J-SUPPORT2401/JORTC-SUP06(J-DIRECT)研究方案

2025-05-140
OA
A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy

ME2136 (马来酸阿塞那平) 加标准止吐治疗的II期研究,用于接受基于顺铂的化疗的患者,包括糖尿病患者

2024-10-260
PRE
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE)
2023-11-060
OAAI